Search - tctmd.com

Displaying 421 - 440 of 469

Sort: Relevancy | Date

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

News Conference News TCT 2013

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

October 30, 2013

Presentation TCT 2013

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Presenter: Michael Rinaldi

October 29, 2013

Presentation TCT 2013

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

Presenter: Francesco Maisano

October 29, 2013

Presentation TCT 2013

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Presenter: Edith Lubos

October 29, 2013

Presentation TCT 2013

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Presentation TCT 2013

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Presenter: Blase Carabello

October 28, 2013

Presentation TCT 2013

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Presenter: Alec Vahanian

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Presenter: Dominique Himbert

October 28, 2013

Presentation TCT 2013

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Presenter: Robert Bonow

October 28, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Presenter: Tim Lapp

October 27, 2013

News Daily News

MitraClip Gains FDA Approval for Nonsurgical Patients

October 25, 2013

News Daily News

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

L.A. McKeown

September 20, 2013

News Daily News

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

L.A. McKeown

September 20, 2013

Presentation

Outcomes of Central vs. Noncentral Percutaneous Repair of Degenerative Mitral Regurgitation

Presenter: R Est?vez-Loureiro

September 06, 2013

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

Advertisement

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

ACCESS-EUROPE, EVEREST II Data Support MitraClip in MR

TCT-93. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High Surgical Risk Patients

Case Presentations: The Issue: Introducing Two Cases of Mitral Regurgitation (One Degenerative MR, One Functional MR) Which Might Invoke Different Approaches

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical...

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature

Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

MitraClip Gains FDA Approval for Nonsurgical Patients

MitraClip Parece Seguro y Eficaz en Pacientes con Regurgitación No Central

MitraClip Appears Safe, Effective for Patients with Noncentral Regurgitatior

Outcomes of Central vs. Noncentral Percutaneous Repair of Degenerative Mitral Regurgitation

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content